Correlation | Serum sE-cadherin, ng/ml | |
---|---|---|
r | rs | |
Age, yrs | 0.25b | |
Disease duration, yrs | 0.24b | |
SLICC | 0.21b | |
Erythrocyte sedimentation rate, mm/h | 0.36a | |
S-creatinine, μmol/l | 0.42a | |
Glomerular filtration rate, ml/minute | −0.53a | |
GFR 50 (< 50 = 1, ≥ 50 = 0) | 0.29a | |
Renal involvement ever by SLE (yes = 1, no = 0) | 0.18c | |
Cholesterol, mmol/l | 0.37a | |
Low-density lipoprotein, mmol/l | 0.19c | |
Triglycerides, mmol/l | 0.36a | |
Interleukin-6, pg/ml | 0.31a | |
MMP-3, ng/ml | 0.31a |
All variables were tested with the Kolmogorov-Smirnov normality test. Pearson correlation was used with the variables were normally distributed, otherwise Spearman correlation was used. Only significant variables are shown.
↵a p < 0.001;
↵b p < 0.01;
↵c p < 0.05. DMARD: disease-modifying antirheumatic drugs; GFR: glomerular filtration rate; r: Pearson correlation coefficient; rs: Spearman correlation coefficient; SLICC: Systemic Lupus International Collaborative Clinics/ACR Damage Index; MMP: matrix metalloproteinase.